Findings suggest that c-Myc-regulated AFAP1-AS1 may contribute to OSCC proliferation through modulation of the miR-655-3p/CCNA2 axis and provide insight into the molecular mechanisms underlying OSCC progression.
Abstract
Objective
This study aimed to investigate the molecular mechanisms by which AFAP1-AS1 promotes proliferation in oral squamous cell carcinoma (OSCC).
Materials And Methods
AFAP1-AS1 expression was examined in OSCC tissues and cell lines. Functional analyses were performed by silencing AFAP1-AS1 in vitro and assessing the resulting changes in CCNA2 expression. Bioinformatic analyses were used to predict microRNAs (miRNAs) potentially interacting with both AFAP1-AS1 and CCNA2, and these interactions were validated using dual-luciferase reporter assays and RNA immunoprecipitation (RIP). Chromatin immunoprecipitation (ChIP) assays were conducted to determine whether c-Myc directly binds to the AFAP1-AS1 promoter, thereby regulating its transcription.
Results
AFAP1-AS1 was significantly upregulated in OSCC tissues and cell lines compared with normal controls. Silencing AFAP1-AS1 led to decreased CCNA2 expression. Both computational predictions and experimental validations indicated that miR-655-3p interacts with AFAP1-AS1 and CCNA2, potentially acting as a regulatory intermediary. ChIP assays further showed that c-Myc directly binds to the promoter region of AFAP1-AS1, suggesting a role in its transcriptional activation.
Conclusion
These findings suggest that c-Myc-regulated AFAP1-AS1 may contribute to OSCC proliferation through modulation of the miR-655-3p/CCNA2 axis and provide insight into the molecular mechanisms underlying OSCC progression.
The ZNF582-AS1/miR-21-5p/miR-516a-3p/CREBRF regulatory axis provides mechanistic insights into EC tumorigenesis and emphasizes the tumor suppressive effect of ZNF582-AS1.
It is indicated that SLC12A9-AS1 is abnormally overexpressed in CRC cells and that its knockdown attenuates malignant phenotypes, at least in part through regulation of miR-139-3p.
Shiyu Zhao, Shuai Zhang, Qiong-Feng Tan et al.· Journal of Visualized Experi...· 0 citations
RASAL2-AS1 exerts a tumor-suppressive effect in cervical cancer by functioning as a competing endogenous RNA (ceRNA) that modulates the miR-590-5p/PDCD5 axis and regulates the Wnt/β-catenin pathway.
Ke Yin, Yi Li, Mengying Tang· Hereditas· 0 citations
OtUD6B-AS1 suppresses EAC progression by sponging miR-145-5p and upregulating AIF to induce parthanatos activation, and Targeting this ceRNA regulatory axis may be a therapeutic strategy for EAC.
Qingfeng Zheng, Qiu-ping Wu, Yuling Lin et al.· American journal of translat...· 0 citations
It is suggested that lnc-DNAJC3-AS1 promotes GC progression, at least in part, through the miR-576-5p/LYPLA1 pathway, providing a potential target for GC treatment.
Zhen-Ni Sun, Ya-Sai Yao, Zhi-Jian Xu et al.· American Journal of Cancer R...· 0 citations
DLGAP1-AS2 acts as a potential biomarker for unfavorable prognosis in ESCC patients and promotes malignant phenotypes of ESCC cells in vitro by regulating the miR-101-3p/EZH2 axis, enhancing proliferation and EMT, while suppressing ferroptosis.